Finance

Lists
ELOX:NASDAQ
Eloxx Pharmaceuticals Inc
$19.14
+12.59%
(+2.14) 1D
Aug 11, 1:54:27 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELOX...
Open
$18.39
High
$19.96
Low
$17.98
Mkt. cap
76.71M
Avg. vol.
65.57K
Volume
39.84K
52-wk high
$19.96
52-wk low
$0.00
Beta
3.62
Shares outstanding
461.00K
No. of employees
10
Open
$18.39
High
$19.96
Low
$17.98
Mkt. cap
76.71M
Avg. vol.
65.57K
Volume
39.84K
52-wk high
$19.96
52-wk low
$0.00
Beta
3.62
Shares outstanding
461.00K
No. of employees
10
About Eloxx Pharmaceuticals Inc
CEO-
Employees10
Founded1999
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeloxxpharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to ELOX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ELOX in the last 3 months.
Highest
Current $19.14
$43.00 (+124.66%)
Average
$41.50 (+116.82%)
Lowest
$40.00 (+108.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rami Katkhuda
LifeSci Capital
Buy
Initiated
$40.00
+109%
07/22/2026
Vamil Divan
Guggenheim
Buy
Initiated
$43.00
+124.7%
07/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2023
Dec 2023
Mar 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
510.00K
1.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
712.00K
2.14M
Operating expense
-
-
1.22M
3.80M
Total operating expenses
-
-
1.22M
3.80M
Operating income
-
-
-1.22M
-3.80M
Other non operating income
-
-
-9.00K
-9.00K
EBT including unusual items
-
-
-1.71M
-3.75M
EBT excluding unusual items
-
-
-1.71M
-3.81M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-1.71M
-3.75M
Net profit margin
-
-
-
-
Earnings per share
-14.41
-
-
-
Interest and investment income
-
-
5.00K
23.00K
Interest expense
-
-
-483.00K
-29.00K
Net interest expenses
-
-
-478.00K
-6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-1.21M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps